Cannabinoid-1 Receptor Blockade in Cardiometabolic Risk Reduction: Efficacy
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference38 articles.
1. Prevalence of overweight and obesity in the United States, 1999–2004;Ogden;JAMA,2006
2. Medical consequences of obesity 2004;Bray;J Clin Endocrinol Metab,2004
3. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease;Matsuzawa;Nat Clin Pract Cardiovasc Med,2006
4. AHA Statistical Update: Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Circulation,2007
5. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular disease;Bergman;Am J Med,2007
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Resistin Regulates Inflammation and Insulin Resistance in Humans via the Endocannabinoid System;Research;2024-01
2. Alterations of the hematologic cells in synthetic cannabinoid users;Journal of Clinical Laboratory Analysis;2017-02-07
3. Safety of antiobesity drugs;Therapeutic Advances in Drug Safety;2013-05-23
4. The Relationship of Childhood Obesity with Cardiomyopathy and Heart Failure;Pediatric Metabolic Syndrome;2012
5. Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway;Acta Pharmacologica Sinica;2010-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3